Literature DB >> 3358765

Presence of digitalis-like factor in mammalian plasma.

A Goto1, K Yamada, M Ishii, M Yoshioka, T Ishiguro, C Eguchi, T Sugimoto.   

Abstract

We attempted to purify a digitalis-like factor from volume expanded dog plasma using an inhibitory effect on the binding of [3H]ouabain to intact human erythrocytes to monitor digitalis-like activity. A highly polar [3H] ouabain displacing compound was purified to a high degree using a combination of chromatographic procedures including reverse phase and gel filtration high performance liquid chromatography. This compound, a reversible inhibitor of [3H]ouabain binding, closely resembles ouabain in its polarity and significantly increases during saline infusion. Its molecular weight was estimated to be 343Da. Moreover, similar compound was consistently detected in other mammalian plasma.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3358765     DOI: 10.1016/s0006-291x(88)80717-4

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  4 in total

Review 1.  Endogenous factors with immunological and biological activity similar to cardiac glycosides: biochemical and pathophysiological implications.

Authors:  A Clerico; G Mariani
Journal:  J Endocrinol Invest       Date:  1992-05       Impact factor: 4.256

Review 2.  [Endogenous natriuretic and ouabain-like factors. Their potential role in volume and blood pressure regulation].

Authors:  H J Kramer; A Bäcker; G Krampitz; H Meyer-Lehnert; H Michel
Journal:  Klin Wochenschr       Date:  1990-11-16

3.  Dissociation of digoxin-like immunoreactivity and Na+,K+-ATPase inhibitory activity in rat plasma.

Authors:  K Yamada; A Goto; M Ishii; M Yoshioka; T Sugimoto
Journal:  Experientia       Date:  1988-12-01

Review 4.  The pump, the exchanger, and the holy spirit: origins and 40-year evolution of ideas about the ouabain-Na+ pump endocrine system.

Authors:  Mordecai P Blaustein
Journal:  Am J Physiol Cell Physiol       Date:  2017-11-07       Impact factor: 4.249

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.